Cargando…
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors
Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical variables, and radiomic phenotypes may improve prediction of E...
Autores principales: | Yousefi, Bardia, LaRiviere, Michael J., Cohen, Eric A., Buckingham, Thomas H., Yee, Stephanie S., Black, Taylor A., Chien, Austin L., Noël, Peter, Hwang, Wei-Ting, Katz, Sharyn I., Aggarwal, Charu, Thompson, Jeffrey C., Carpenter, Erica L., Kontos, Despina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113313/ https://www.ncbi.nlm.nih.gov/pubmed/33976268 http://dx.doi.org/10.1038/s41598-021-88239-y |
Ejemplares similares
-
Impact of Interobserver Variability in Manual Segmentation of Non-Small Cell Lung Cancer (NSCLC) Applying Low-Rank Radiomic Representation on Computed Tomography
por: Hershman, Michelle, et al.
Publicado: (2021) -
Improved generalized ComBat methods for harmonization of radiomic features
por: Horng, Hannah, et al.
Publicado: (2022) -
Generalized ComBat harmonization methods for radiomic features with multi-modal distributions and multiple batch effects
por: Horng, Hannah, et al.
Publicado: (2022) -
Are radiomic signatures ready for incorporation in the clinical pipeline?
por: Singh, Apurva, et al.
Publicado: (2023) -
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
por: Singh, Apurva, et al.
Publicado: (2022)